We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+7.87%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$9.04B
AUM Growth
+$2.19B
Cap. Flow
+$1.88B
Cap. Flow %
20.78%
Top 10 Hldgs %
34.88%
Holding
3,092
New
1,032
Increased
581
Reduced
587
Closed
820

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$435M
2
AMZN icon
Amazon
AMZN
+$334M
3
MRNA icon
Moderna
MRNA
+$53.9M
4
LIN icon
Linde
LIN
+$44.2M
5
DTE icon
DTE Energy
DTE
+$43.5M

Sector Composition

Rank Sector Weight
1 Technology 15.37%
2 Consumer Discretionary 10.36%
3 Financials 7.14%
4 Industrials 6.8%
5 Healthcare 6.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SHG icon
2751
Shinhan Financial Group
SHG
$35B
-9,984
Closed -$335K
SHO icon
2752
Sunstone Hotel Investors
SHO
$2.1B
-24,605
Closed -$307K
SHOO icon
2753
Steven Madden
SHOO
$3.37B
-63,625
Closed -$2.37M
SID icon
2754
Companhia Siderúrgica Nacional
SID
$1.3B
-122,829
Closed -$823K
SIGI icon
2755
Selective Insurance
SIGI
$5.45B
-4,499
Closed -$326K
SIRI icon
2756
PUT
SiriusXM
SIRI
$9.67B
-20,010
Closed -$1.22M
SKIN icon
2757
SkinHealth Systems
SKIN
$85M
-18,868
Closed -$204K
SKT icon
2758
Tanger
SKT
$4.39B
-74,218
Closed -$1.12M
SLAB icon
2759
Silicon Laboratories
SLAB
$7.27B
-9,984
Closed -$1.41M
SLG icon
2760
SL Green Realty
SLG
$4.07B
-39,074
Closed -$2.73M
SLRC icon
2761
SLR Investment Corp
SLRC
$689M
-41,721
Closed -$741K
SMMT icon
2762
Summit Therapeutics
SMMT
$10.5B
-93,533
Closed -$549K
SMSI icon
2763
Smith Micro Software
SMSI
$16.7M
-1,054
Closed -$232K
SNAP icon
2764
PUT
Snap
SNAP
$8.86B
-2,214,000
Closed -$116M
SNCY
2765
DELISTED
Sun Country Airlines
SNCY
-11,546
Closed -$396K
SNDX icon
2766
Syndax Pharmaceuticals
SNDX
$1.75B
-10,359
Closed -$232K
SNN icon
2767
Smith & Nephew
SNN
$12.2B
-15,280
Closed -$579K
SON icon
2768
Sonoco
SON
$5.88B
-13,264
Closed -$840K
SONY icon
2769
Sony
SONY
$140B
-154,985
Closed -$3.29M
SOS
2770
SOS Limited
SOS
$17.9M
-14
Closed -$51K
SPG icon
2771
Simon Property Group
SPG
$70.6B
-2,973
Closed -$338K
SPHR icon
2772
Sphere Entertainment
SPHR
$5.69B
-3,743
Closed -$306K
SR icon
2773
Spire
SR
$4.78B
-8,338
Closed -$616K
SSB icon
2774
SouthState Bank Corp
SSB
$10.4B
-24,534
Closed -$1.93M
SSD icon
2775
Simpson Manufacturing
SSD
$7.74B
-17,806
Closed -$1.85M

Similar funds

Michael Gelband's Q2 2021 Portfolio in Review

As of Q2 2021, Michael Gelband held 3,092 positions worth $9.04B, up 32% from $6.86B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Michael Gelband deployed $1.88B of net new capital in Q2 2021, opening 1,032 new positions and adding to 581 existing holdings. Its largest new stake was Linde: 151,692 shares worth $43.9M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Russell 1000 Value ETF, an estimated $63.6M trimmed.

  • Michael Gelband's largest Q2 2021 buy was Linde: 151,692 shares worth $43.9M.
  • Michael Gelband added most to Microsoft in Q2 2021, an estimated $435M increase.
  • Michael Gelband's biggest Q2 2021 reduction was iShares Russell 1000 Value ETF, cutting an estimated $63.6M.
  • Michael Gelband fully exited Charles River Laboratories in Q2 2021, selling an estimated $27.9M.
  • Michael Gelband's ten largest holdings make up 35% of its $9.04B portfolio in Q2 2021.
  • Michael Gelband opened 1,032 new positions and closed 820 in Q2 2021.
  • Michael Gelband's portfolio value rose 32% quarter-over-quarter to $9.04B.

Based on ExodusPoint Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.